Thromb Haemost 1997; 78(03): 0984-0986
DOI: 10.1055/s-0038-1657672
Rapid Communication
Schattauer GmbH Stuttgart

Coagulation Factor VII, Serum-Triglycerides and the R/Q353 Polymorphism: Differences between Older Men and Women

Louise I Mennen
1   The Department of Epidemiology and Biostatistics, Erasmus University Rotterdam, The Netherlands
2   The Department of Epidemiology and Public Health, Agricultural University Wageningen, The Netherlands
,
Moniek P M de Maat
3   The Gaubius Laboratory, TNO-PG Leiden, The Netherlands
,
Evert G Schouten
2   The Department of Epidemiology and Public Health, Agricultural University Wageningen, The Netherlands
,
Cornelis Kluft
3   The Gaubius Laboratory, TNO-PG Leiden, The Netherlands
,
Paulus T V. M de Jong
4   The Netherlands Ophthalmic Research Institute, Amsterdam, The Netherlands
5   The Academic Medical Centre, Amsterdam, The Netherlands
,
Albert Hofman
1   The Department of Epidemiology and Biostatistics, Erasmus University Rotterdam, The Netherlands
,
Diederick E Grobbee
1   The Department of Epidemiology and Biostatistics, Erasmus University Rotterdam, The Netherlands
6   The Julius Center for Patient Oriented Research, Utrecht University, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 14 1997

Accepted after revision 05 June 1997

Publication Date:
12 July 2018 (online)

Summary

Coagulation factor VII activity (FVIIC) is a risk indicator for cardiovascular disease. It is related to serum-triglycerides and the R/Q353 polymorphism (alleles R and Q) in the gene coding for factor VII is strongly associated with factor VII. The association of serum- triglycerides with factor VII may differ between the genotypes, but the results of earlier studies were inconsistent and did not include older people. We studied FVII, triglycerides and the R/Q353 polymorphism in the Rotterdam Study.

In 1158 older subjects (489 men and 669 women) FVIIC, factor VII: Chr, serum-triglycerides and the R/Q353-genotype were determined.

In women triglycerides were positively associated with FVIIChr and FVIIC (FVIIChr: β = 12.4 % PP/mmol/L, CI: 10.3-14.5; FVII:C: β = 13.1% PP/mmol/L, CI: 10.4-15.8). These associations varied by genotype (FVII:Chr: RR: β = 11.7, CI: 9.6-13.8, RQ/QQ: β = 7.9, CI: 4.6-11.2; FVII:C: RR: β = 12.5, CI: 9.5-15.5, RQ/QQ: β = 6.4, CI: 1.4-11.4).

In men, the associations of FVII:Chr and FVII:C with triglycerides were weaker (FVII:Chr: β = 5.9, CI: 4.1-7.7; FVII:C: β = 8.7, CI: 6.2-11.2). There was no difference between the genotype groups.

These results suggest that only in older women the strength of the association of factor VII with serum-triglycerides varies according to genotype of the R/Q353 polymorphism.

 
  • References

  • 1 Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. The Lancet 1986; 06: 533-537
  • 2 Assmann G, Cullen P, Heinrich J, Schulte H. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Munster heart study (PROCAM). Isr J Med Sci 1996; 32: 364-370
  • 3 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546
  • 4 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
  • 5 Kario K, Matsuo T, Kario T, Kobayashi H. Sex-related differences in the relationship between plasma factor VII levels and serum lipids, lipoproteins and apolipoproteins. Thromb Res 1991; 64: 69-73
  • 6 Tervahauta M, Pekkanen J, Kivinen P, Stengård J, Jauhiainen M, Ehnholm C, Nissinen A. Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries Study. Atherosclerosis 1993; 104: 47-59
  • 7 Marckmann P, Sandstrӧm B, Jespersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992; 96: 235-244
  • 8 Donders SHJ, Lustermans FAT, van Wersch JWJ. Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients. Scand J Clin Lab Invest 1993; 53: 179-186
  • 9 Donders SHJ, Lustermans FAT. Glycometabolic control, lipids, and coagulation parameters in patients with non-insulin-dependent diabetes mellitus. Int J Clin Lab Res 1993; 23: 155-159
  • 10 Bemardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vase Biol 1996; 16: 72-76
  • 11 Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198
  • 12 Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
  • 13 Saha N, Liu Y, Heng CK, Hong S, Low PS, Tay JSH. Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy indian adults and interaction with triglycerides. Arterioscler Thromb 1994; 14: 1923-1927
  • 14 Heywood DM, Mansfield MW, Grant PJ. Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulindependent-diabetes mellitus. Thromb Haemost 1996; 75: 401-406
  • 15 Meilahn E, Ferrell R, Kiss J, Temple A, Green F, Humphries S, Kuller L. Genetic determination of coagulation factor VIIc levels among healthy middle-aged women. Thromb Haemost 1995; 73: 623-625
  • 16 de Maat MPM, Green F, de Knijff P, Jespersen J, Kluft C. Factor VII polymorphisms in populations with different risk of cardiovascular disease. Arterioscler Thromb Vase Biol. (in press)
  • 17 Hofman A, Grobbee DE, de JongPTVM, van den OuwenhandFA. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991; 07: 403-422
  • 18 Avvisati G. Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant treatment. Br J Haematol 1980; 45: 343-352
  • 19 Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
  • 20 Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 1996; 75: 567-572
  • 21 Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de LooJ, Kienast J, Wu KK, Morrissey JH, Meade TW, Martin JC, Imeson JD, Cooper JA, Finch A. Factor VH-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71: 38-48